“…The role of pro-inflammatory (TNF-α, IFN-γ, IL-6) and anti-inflammatory (IL-4, IL-10) biomarkers has exhaustively been researched. However, the optimal treatment for SIRS is complicated by this multi-factorial nature of inciting agents and varied immune response in the clinical setting [4,5].…”